Outcomes in youth-onset type 2 diabetes during the transition period: glycemic control, microvascular complications, and effects of second-line agents
Annals of Pediatric Endocrinology & Metabolism · 28.02.2026 · 31 (1) · 45-54
DOI: 10.6065/apem.2550068.034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Pediatric Endocrinology & Metabolism, erschienen am 28.02.2026. Verfasst von Jeesun Yoo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Korea. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Purpose
Despite the global paradigm emphasizing earlier and more aggressive intervention for youth-onset type 2 diabetes mellitus (T2DM), metformin and insulin are the only drugs approved for Korean adolescents. We investigated the incidence of complications, changes in glycemic control during the transition period, the effect of second-line antidiabetic agents on glycemic control in young adults with youth-onset T2DM.
Methods
Eighty-four patients diagnosed with T2DM at Seoul National University Children's Hospital between January 2001 and July 2023, before age 18 (47 males; mean age, 14 years) with available glycated hemoglobin (HbA1c) data from at least 2 distinct ages between 19 and 22 years old were retrospectively enrolled.
Results
At the last follow-up (mean age, 24.9 years; median follow-up, 9.6 years), complications were found in 33.7% (nephropathy, 25.3%; eye disease, 20.6%), and 83% required insulin or second-line agents. During the transition period, HbA1c levels decreased from 8.2% at age 19 to 7.7% at age 22 (P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Korea.
- Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea.
Zitieren
APA
Yoo, J., Lee, Y. J., Shin, C. H., & Lee, Y. A. (2026). Outcomes in youth-onset type 2 diabetes during the transition period: glycemic control, microvascular complications, and effects of second-line agents. Annals of Pediatric Endocrinology & Metabolism, 31(1), 45-54. https://doi.org/10.6065/apem.2550068.034
Vancouver
Yoo J, Lee YJ, Shin CH, Lee YA. Outcomes in youth-onset type 2 diabetes during the transition period: glycemic control, microvascular complications, and effects of second-line agents. Annals of Pediatric Endocrinology & Metabolism. 2026;31(1):45-54. doi:10.6065/apem.2550068.034
BibTeX
@article{Yoo2026,
author = {Yoo, Jeesun and Lee, Yun Jeong and Shin, Choong Ho and Lee, Young Ah},
title = {Outcomes in youth-onset type 2 diabetes during the transition period: glycemic control, microvascular complications, and effects of second-line agents},
journal = {Annals of Pediatric Endocrinology & Metabolism},
year = {2026},
volume = {31},
number = {1},
pages = {45--54},
doi = {10.6065/apem.2550068.034}
}
EUVIMED